Schedule 13G ownership disclosure
ARRAY BIOPHARMA INC
Security class unavailable · CUSIP: 04269X105
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 19,113,864
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001425738-18-000003
- Form type
- SC 13G
- Filer
- ARRAY BIOPHARMA INC
- CIK
- CIK 1100412
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership